An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound
Clinical trial NCT04488185 · WITHDRAWN
Trial details
- NCT number
- NCT04488185
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2021-03-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.